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This research focused on developing an efficient TIRF microscopy approach to evaluate 
membrane protein organization. More specifically, the data demonstrate that TIRF 
microscopy can detect changes in ex vivo B-cell MHC II lateral organization using a 
monoclonal antibody under differing conditions. MHC II clustering is dependent on the 
underlying lipid environment and upon LPS stimulation MHC II expression is 
dramatically increased. Using mice fed a fish oil or control diet for three weeks, or using 
mice aged for nine months, we imaged splenic B-cell MHC II clustering using TIRF 
microscopy. We also used LPS to stimulate B-cells from both experimental conditions to 
determine if either ageing the animals or feeding them fish oil could affect MHC II 
clustering. We then determined cluster quantity, size, and intensity using the NIH 
ImageJ software. The data showed that neither a relevant dose of fish oil, nor aging the 
mice approximately nine months, had an affect on MHC II clustering in the absence of 
LPS stimulation. However upon LPS stimulation, MHC II clustering dramatically 
changed in aged mice as well as fish oil fed mice compared to control animals. Taken 
together, the data establish the TIRF microscopy protocol as a relevant alternative 
tomore costly and time consuming approaches to address membrane protein clustering. 
Moreover, either ageing the animals or feeding them fish oil significantly affects MHC II 
clustering upon stimulation with LPS.
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Chapter 1: Literature Review 
1.1 The plasma membrane and membrane microdomains 
 The plasma membrane consists of an amphipathic phospholipid bilayer and 
membrane proteins and each of these components serve several important biological 
functions necessary for life to exist. In 1925, the findings of Gorter and Grendel 
demonstrated the first evidence for the existence of phospholipid bilayers using red 
blood cells (1).  Their results were later bolstered in the 1950’s with electron micrographs 
demonstrating visual confirmation of the lipid bilayer (2). Since these early investigations 
into the plasma membrane, the scientific understanding of what the plasma membrane 
is and how it functions has advanced tremendously. The theoretical underpinning of the 
most widely taught membrane model is the Singer and Nicolson fluid mosaic model first 
published in 1972 (3). The fluid mosaic model hypothesizes unrestricted and random 
movement of lipids and proteins that make up the plasma membrane (3). The Singer and 
Nicolson model predicts proteins are mainly monomeric and dispersed at relatively low 
concentrations in a “sea of lipids” with little to no preferential association between 
proteins or proteins and lipids (3, 4). While this model was the initial paradigm that built 
the foundational understanding of the molecular components of the plasma membrane, 
the unrestricted lateral diffusion and lack of lateral heterogeneity described in the Singer 
and Nicolson model has been challenged over the past forty years (4, 5).  With the 
advancements in microscopy, cell biophysics, molecular biology, and other technologies 
and techniques it has become apparent the plasma membrane is not an unrestricted 
fluid bilayer where membrane lipids and proteins move about freely and interact 
randomly (3, 4). Instead, as Donald Engelman states, “membranes are more mosaic than 
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fluid” containing much more protein than suggested by the fluid-mosaic model and, 
while Singer and Nicolson described the “standard conceptualization of membrane 
architecture”, the generalizations made in their model are widely ineffective at 
describing our current understanding of the structure and function of the plasma 
membrane (4).  
 Since the development and subsequent publication of the fluid mosaic model a 
substantial amount of data demonstrate that the membrane exhibits lateral 
heterogeneity in its structure through preferential association of its molecular 
components (5). The membrane is now characterized into the inner and outer leaflets 
within which particular lipids are found. Four phospholipids characterize more than half 
of the lipids in the plasma membrane: phosphotidylserine, phosphotidylethanolamine, 
phosphotidylcholine, and sphingomyelin (4, 6, 7). Phosphotidylcholine and sphingomyelin 
are mainly found in the in the outer leaflet of the plasma membrane while the 
phosphotidylethanolamine and phosphotidylserine are typically found in the inner leaflet 
(7). Glycolipids and cholesterol are other lipids that make up the membrane with 
cholesterol being a major constituent in ratios similar to that of phospholipids (8). 
Glycolipids are exclusively found in the outer leaflet of the membrane due to its sugar 
moieties (7). Within these lipid constituents of the plasma membrane, proteins and 
protein complexes interact with the extracellular environment and stimuli in order for the 
cell to function. Studies investigating the interactions and relationships of lipids and 
proteins in the membrane, i.e. membrane dynamics, demonstrate that instead of 
randomness and unrestricted movement of these two components there exists a 
preferential association of lipids, proteins, and lipid-protein domains of the plasma 
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membrane (5, 9). Unique associative properties of particular lipids demonstrate lateral, or 
lipid, phase separation (5). For example, in vitro studies demonstrate sphingolipid and 
cholesterol self associate to form domains thus demonstrating lateral segregation is 
possible within membranes based on lipid interactions alone (5). The phase separation 
demonstrated in these studies was cholesterol dependent. The interactions between 
saturated fatty acyl chains of membrane lipids and cholesterol are favorable leading to 
an increase in membrane thickness and segregation into what are known as liquid order 
phases or microdomains (5). These microdomains are vital for compartmentalizing 
particular proteins and lipids that create a functional patchiness that facilitates protein-
protein interactions to help propagate protein signaling and cellular function (5, 10, 11). 
Some studies argue that most, if not all, plasma membrane proteins are clustered into 
protein “islands” that are dependent on their surrounding lipid environment to remain 
intact (12). However, multiple membrane proteins are known to cluster in response to a 
ligand binding a specific receptor. This causes multiple proteins to be recruited and 
signaling complexes to be formed. This process is often dependent on membrane 
microdomains known as “lipid rafts” (5, 13). Lipid rafts consist of sphingolipids, 
glycosphingolipids, and cholesterol (5, 6).  
 Lipid rafts were proposed to explain how glycosphingolipids are enriched at the 
apical surface of polarized epithelia cells (14). Thus, rafts represent a segment of 
nonrandom membrane organizing functionality within the membrane. The lipid 
component of lipid rafts are vital, however the protein within the rafts are what carry out 
the function recognizing ligands and initiating signaling. In a state where a ligand is not 
present, lipid rafts are transient dynamic nanoscale microdomains that are cholesterol 
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dependent. These nanoscale rafts can be stabilized and coalesce through interactions 
of proteins with ligands and signaling complexes to form larger “raft platforms” and, in 
theory, a “raft phase” that is more dependent on the lipid-protein/protein-protein 
interactions than lipid-lipid self association (5). However, not all proteins contain the 
properties to associate and compartmentalize within rafts. Thus, one characterization of 
proteins is whether they are raft or non-raft resident proteins. This is demonstrated by 
antibody crosslinking of proteins that cluster with rafts excluding other proteins that do 
not show a sterol preference. Thus, many membrane receptors necessary for cellular 
function are known to localize within lipid rafts upon ligand stimulation (5, 8, 15, 16). The 
ability for the membrane to form this raft based heterogeneity to selectively 
compartmentalize proteins that propagate signaling is a vital function that maintains 
both cell and whole organism function (8, 15, 16).  
1.2 B-lymphocytes and protein clustering 
 Lymphocytes are a class of white blood cells that include B and T-
lymphocytes(17). Both cell types are vital for adaptive immunity. B-lymphocytes are 
responsible for humoral immunity while T lymphocytes are responsible for cell 
meditated immunity (17). The former is the primary cell type discussed in this thesis and 
will be referred to as B-lymphocytes and B-cells interchangeably. B-lymphocytes 
originate in the fetal liver and adult bone marrow from hematopoietic multipotent stem 
cells (18). The development of B-lymphocytes in the bone marrow are defined by the 
expression of cell surface markers that are used to characterize what stage of 
development the B-lymphocytes are in (18). Immature B-lymphocytes are defined by the 
expression of membrane bound immunoglobulin mu (IgM) on their surface (17, 18). When 
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IgD is concurrently expressed on the surface the B-cell it is considered a mature naïve 
B-cell. They are considered naïve because the B-cell has not encountered its specific 
antigen with an epitope capable of activating that particular B-cell (17). Each membrane 
bound immunoglobulin recognizes a specific antigenic epitope unique to that B-cell (17, 
19). Following the development of a mature naïve B-lymphocyte, B-cells enter circulation 
and secondary lymphoid organs (e.g. lymph nodes and the spleen) where they 
encounter their specific antigen and functionally mature (18). Membrane bound 
immunoglobulins, such as IgM, are a critical component of the B-cell receptor (BCR) 
whose function is responsible both for B-cell development in the bone marrow and 
functional maturation in the periphery (18). The BCR also contains Ig-alpha and Ig-beta, 
which have cytoplasmic domains that contain immunoregulatory tyrosine based 
activation motifs (ITAMS) (18, 20). Since the cytoplasmic tails of the membrane bound 
immunoglobulin component of the BCR are not capable of transducing signaling events, 
it is Ig-alpha and beta that initiate intracellular signaling events through phosphorylation 
of their ITAM domains (20, 21). Thus in a mature naïve B lymphocyte in the periphery, the 
IgM component of the BCR binds the specific antigen while Ig-alpha and beta facilitate 
the initiation of the intracellular signaling events leading to B-cell activation (10, 21). The 
functional endpoint of B-lymphocytes after encountering immunogenic antigens within 
secondary lymphoid organs is to produce antibodies through differentiating into plasma 
cells or forming memory B-cells that are capable of producing antibodies upon a later 
encounter with that specific antigen (18). These antibodies are soluble immunoglobulins 
specific for the same antigen that is initially recognized by the BCR. There are five 
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isotypes of immunoglobulins, determined by the constant region of their heavy chains, 
that are found in both the BCR and as antibodies: IgM, IgD, IgA, IgE, and IgG. 
 Lymphocytes and their membrane bound immunoglobulins have played an 
integral part in helping to amend and evolve the fluid-mosaic membrane model (4). In the 
1970’s murine splenic B-cells showed capping of IgM and IgD to one ‘pole’ of the cell in 
response to specific antisera (22). Moreover as early as 1976, four years after the fluid 
mosaic model was published, IgM and IgD were shown to co-cap in response to specific 
antigens (22). This cocapping demonstrated that the prediction of nonrandom interactions 
between proteins of the plasma membrane by the fluid mosaic model was incorrect. 
Lymphocytes were also used to demonstrate that the plasma membranes and its 
molecular components are very dynamic, constantly changing depending what 
environment the lymphocyte is responding to.  However, the discovery of 
supramolecular protein complexes using lymphocytes, as well as other cell types, has 
been critical to both understanding immunological function of organisms as well as 
understanding the interactions of lipids and proteins within the plasma membrane. For 
example, Susan Pierce and colleagues research addressing the initiation of B-cell 
activation demonstrates that once presented with antigen through planar bilayers, B-
cells containing specific BCRs capable of recognizing that particular antigen initially 
form microclusters of immobilized BCRs leading to eventual recruitment and localization 
of larger quantities of BCRs to immunological synapse between the artificial bilayer and 
the B-cell (21). Moreover, they demonstrated that initial BCR microclusters recruit lipid 
rafts containing the Src family kinase Lyn to proporgate signaling and begin the process 
of activating the B-cell. Other studies addressing B-cell recognition of T-cell dependent 
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antigens, antigen processing, and subsequent antigenic peptide presentation to CD4+ 
T-cells are some of the most eloquent examples of membrane dynamics and protein 
clustering (23, 24). In secondary lymphoid organs such as the spleen B-cells encounter T-
cell dependent antigens that require not only the recognition of BCR but also the 
function of another membrane raft resident protein major histocompatibility complex II 
(MHC II). MHC II is a central protein for antigen presentation to CD4+ T cells via antigen 
presenting cells (APCs) (25). In APCs, such as the B-cell, MHC II is loaded intracellularly 
with specific peptides derived from a processed antigen (26, 27). It then presents this 
peptide-MHC II complex to CD4+ T cells for recognition through a cognate T cell 
receptor (TCR) (28, 29). How the T cell is able to find the specific peptide-MHC II complex 
for its TCR is highly debated. However, multiple studies indicate that MHC II will cluster 
on APC’s once loaded with peptide (30). Clustering of peptide-MHC II complexes 
depends on the ability of the complex to activate the T cell (30). This means the more 
agonistic peptide-MHC II complexes associate with one another while the less agonistic 
associate together. This allows for efficient recognition of peptide-MHC II complexes 
that will recognize the T cell receptor of CD4+ T cells and is vital for responding to T-
dependent antigens (30). This process is vital for the development of plasma cells, 
germinal centers, and memory B-cells that make up humoral immunity and is raft 
dependent. MHC II expression has been shown to sensitive to activation with 
lipopolysaccharide using flow cytometry and its spatial distribution is sensitive to 
changes in the lipid composition of the plasma membrane. However, the majority of the 
studies that investigate MHC II peptide presentation to CD4+ T-cells, expression, or 
clustering utilize transfection models or other methods that bring into question the 
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physiological relevance of the techniques and protocols. This research utilizes murine 
splenic B-cells MHC II to develop a different approach to study the micron scale MHC II 
clustering utilizing total internal reflection fluorescent microscopy. 
1.3 Fish oil 
 Fish oil is found in different types of oily fish and is rich in n-3 polyunsaturated 
fatty acids (n-3 PUFAs), also known as omega-3 fatty acids (31, 32).  This terminology is 
derived from the position of the double bond that closest to the last methyl group or 
“omega” carbon. Counting the terminal methyl on the acyl chain as the first carbon, 
omega-3 fatty acids have the closest double bond on the third carbon. While there are 
several omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid 
(EPA) are the bioactive omega-3 fatty acids found in fish oil. These two long chain 
omega-3 fatty acids can be derived from the simplest member of the omega-3 fatty acid 
family, alpha-linolenic acid (33).  However, this conversion is poor in vivo and to obtain 
significant amounts of DHA and EPA each must be consumed through the diet (33). 
Moreover, increased intake of DHA and EPA lowers the amount of arachidonic acid. 
This is beneficial as arachidonic acid is a substrate for eicosanoids that have well-
established roles in inflammatory conditions such as asthma (33). 
 Fish oil is currently being explored as immunotherapeutic agent to suppress 
several inflammatory diseases (34, 35), but it cannot be classified solely as an 
immunosuppressant because other studies demonstrate that it can also enhance 
specific immune responses (36, 37). For example, fish oil can attenuate Th1 T-cell function 
while enhancing Th2 T-cell function (38, 39). Thus, immuno-suppression depends on the 
cell and type of immune function studied. Moreover, since the mechanism of fish oil is 
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not known, it makes it difficult to predict how it will respond in different physiological 
conditions and limits the ability to use fish oil in a clinical setting. Several mechanisms 
are suggested to explain how fish oil functions and each of theses are not considered to 
be mutually exclusive (40). While fish oil can act via membrane receptors such as 
GPR120 it has also been postulated to alter the lipid content of the plasma membrane 
and thereby affect protein clustering and function (33). More specifically, it has been 
hypothesized that the ability of fish oil to affect the composition of the lipid component of 
the membrane could affect membrane order and thus subsequent membrane 
microdomains such as lipid rafts. This could thereby affect intracellular signaling and 
gene expression.  
1.4 Ageing 
 Ageing is the progressive and irreversible loss of function accompanied by 
increasing mortality with advancing age. How the ageing process affects the immune 
system is a matter of debate. Generally speaking, the classical view was considered 
that the immune was in a unidirectional decline in function with age (41). However, more 
recently the model has shifted towards a more balanced view of immunosenescence in 
which particular immunological functions and cell populations increase while others 
decrease. For example, Th1 cytokines are increased while Th2 cytokines are decreased 
(42). Thus, determining how ageing affects the immune system cannot be generalized 
and must be put into context as to what immunological cell type and function one is 
examining. 
  Another paradigm of aging is the inability to produce an optimal immune 
response to vaccines and infectious agents (42). One explanation for such a decline to 
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vaccines is that ageing reduces the humoral response in both a qualitative and 
quantitative manner. High affinity antibodies produced by specific subsets of 
differentiated B-cells make up the humoral immune response (18). In aged animals 
germinal center reactions and that drive B-cell differentiation and somatic hypermutation 
to produce antibodies with high affinity for their particular antigen are effected greatly 
(42). This is potentially from a combination of intrinsic B-cell defects and non-intrinsic B-
cell defects such as decreased T-cell and follicular dendritic cell function. Interestingly, 
the majority of the literature concerning how ageing affects these and other 
immunological responses focus more on T-cells and dendritic cells and not B-cells (41). 
The few studies that have addressed B-cell defects with ageing have focused how 
ageing affects B-cell subset population and antibody formation and production (42). While 
this research is vital in developing an understanding of how ageing affects the immune 
system much more research is needed to determine exactly what ageing does to 
differentially affect the immune system. One limiting factor to studying ageing are the 
models available and the translation of physiological relevance of these models to 
humans (42). While some studies have used human immune cells to reach conclusions 
on how ageing affects immune function and cell populations these findings are often 
different than what are found in mice. Thus, much more research is needed in all facets 
of study regarding the immune system in aged animals and humans. 
1.5 Total internal reflection fluorescence microscopy  
 The history of the microscope is unclear regarding its origin. The first attempt to 
piece together the history of the instrument was Dr. Charles Singer in 1914 (43). Dr. 
Singer, along with others, believed the first use of magnification was likely “spheres of 
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glass filled with water”. In addition in the third century B.C. writings clearly discuss the 
optical properties of curved mirrors (43). However, the use of microscopy to address the 
molecular underpinnings of cellular processes begins with the discovery and use of 
lenses (43). In 1590, building on the use of lenses for eyesight, Hans and Zaharias 
Janssen are credited with making the first compound microscope (43). The expansion of 
the instruments importance came through Robert Hooke’s publication Micrographia in 
1665. It was Hooke who coined the term cell when using a microscope to view a piece 
of cork (44). Anthony Van Leeuwenhoek drew on Hooke’s publication using the 
microscope and considerably improved the optical quality and use of the instrument. 
Leeuwenhoek’s (45) contributions were so significant some have credited him as the 
father of microscopy (45).  
 Since the time of Hooke and Leeuwenhoek, many have contributed to the 
evolution of microscopes in several fields of science establishing the instrument as vital 
for scientific research. One major advance in the field of microscopy came with the 
development of total internal reflection microscopy (TIRF) also known as evanescent 
wave microscopy. While the concept of total internal reflection had been used in a 
nonmicroscopic spectroscopy the first form of total internal reflection used in microscopy 
coupled with fluorescence was done by Dr. Axelrod in 1981 (46).  Total internal reflection 
combined with fluorescence allows for the ability to confine fluorescence excitation to a 
thin section (however, just how thin is a matter of debate) close to the cell-substrate 
interface in an aqueous environment (47). This technique provides a very good signal to 
noise ratio by minimizing out of focus background fluorescence. Thus, TIRF has 
numerous applications in biochemistry and cell biology. Traditionally it has been difficult 
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with epifluorescense or confocal microscopy to studying events at or near the plasma 
membrane because these events are obscured by fluorescence that originates within 
the cytosol (47). Due to the thin sectioning available through TIRF, biological processes 
occurring at the plasma membrane are not difficult to image.  
 Through the use of TIRF many cellular actions and components are able to be 
studied with extreme clarity such as actions of the cytoskeleton, endo- and exocytosis, 
and proteins found in the plasma membrane. For example, TIRF revealed that 
microtubules extend immediately adjacent to the plasma membrane in vesicle 
trafficking(48). Another expansive area of focus involving studies that use TIRF are to 
reveal intracellular processes of clathrin-coated vesicles during endocytosis (49). 
However, using TIRF to explore the spatial and temporal dynamics of membrane 
proteins has been expansive. Dr. Susan Pierces work evaluating the protein molecular 
organization up the activation of B-cells exemplifies the utility of TIRF (21). Through using 
antigen load planar bilayers attached to glass coverslips and live cell imaging Dr. Pierce 
has challenged the view that the B-cell receptor requires a multivalent antigen to induce 
crosslinking. Her data collected with TIRF points to an intrinsic ability of the B-cell 
receptor to cluster and initiate signaling without the requirement of multivalent antigens 
(21). 
 Other excellent examples of TIRF contributions to expand on membrane protein 
molecular organization is the work of Dr. Sam Cushman and Dr. Jonathan Bogan 
concerning glucose transporter 4 (50, 51). While differing in their conclusions of the 
regulation and molecular pathway of GLUT4, both used adipocytes transfected with a 
fluorophore tagged to GLUT4 proteins. More specifically, Dr. Cushman designed an 
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eloquent system with primary adipocytes where in which he used a pH sensitive 
fluorophore attached to GLUT4 to determine its docking and dispersion processes at 
the plasma membrane (51). While these studies are impressive and utilize TIRF as the 
primary instrument for study, these techniques consume both time and budget. The 
data here present an alternative method to more cumbersome approaches.
 Chapter 2: Methods 
2.1 Mice and cells 
 Splenic B220+ B-cells were isolated from male C57BL/6 mice as previously 
described (52), regardless of the treatments and/or conditions used to evaluate B-cell 
MHC II clustering. Purity of the B-cells was verified with flow cytometry as previously 
described (37). For experiments utilizing dietary fish oil, mice were fed either a control or 
fish oil diet for three weeks. The content of the fish oil diet is 5% of the total fat by 
weight, which represents approximately four grams of fish oil consumed per day for a 
human, which models current recommended dosage for treating hypertriglyceridemia. 
Experiments using methylbetacyclodextrin (MBCD), cytochalasin D, and 
lipopolysaccharide were conducted using splenic B220+ B-cells from mice 
approximately the same age as those fed the control and fish oil diets. Splenic B-cells 
used in the ageing experiments were from mice that were nine months old. Select 
studies from the fish oil and aged mice were conducted as blinded experiments. All 
experiments followed the guidelines set in place by East Carolina University for the 
euthanasia and humane treatment of animals. 
2.2 Reagents, equipment, and antibodies 
 B-cells were stained with 2 ng/µl of M5/114 MHC II antibody conjugated to Cy3. 
MHC II expression and clustering was measured using an Olympus IX-71 microscope 
modified with Olympus’s cell TIRF system as described previously (37). Experiments 
treating B-cells with lipopolysaccharide (Sigma) and methylbetacyclodextrin (Sigma) 
were done at the same dosage and time frame as previously published (37).  For some 
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experiments, B-cells were treated with cytochalasin D (Sigma) at 2 µg/mL for 15 
minutes to prevent actin polymerization. In all experiments, cells were fixed with 4% 
paraformaldehyde (PFA) for 30 minutes (Electron Microscopy Sciences) before staining 
with MHC II. 
2.3 TIRF Protocol 
 During the isolation of the splenic B220+ B-cells, autoclaved sterile glass cover 
slips (Corning) placed in 60 mm culture dishes were coated with poly-D-lysine (Sigma) 
for 30 minutes in a sterile environment. The number of cover slips to be coated was 
determined by the number of samples needed with one cover slip placed in one culture 
dish. Each sample was done in duplicate. Coating the slides for a longer than 30 
minutes did not increase the number of cells adhered nor did it improve TIRF image 
resolution. When covering the slides with sample, it was imperative that enough poly-D-
lysine was added to completely cover the glass cover slips and that the cover slips were 
not floating on top of the poly-D-lysine solution but submerged within the solution. 
During the 30-minute coating process, isolated splenic B220+ B-cells were counted and 
suspended in fresh RPMI media containing 5% fetal bovine serum, 2 mM L-glutamine, 
and 2% penn/strep (RPMI media) at a concentration of 1 million per mL and placed in 
the incubator at 370 C.  
 Following the 30-minute incubation period, the poly-D-lysine was removed. The 
poly-D-lysine solution covering the cover slips could be reused up to two times. Thus, if 
the poly-D-lysine had not been used more than twice the excess was placed into an 
appropriate container of used poly-D-lysine solution. After the removal of the poly-D-
lysine, each 60 mm culture dish containing a coated glass cover slip was washed three 
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times with a 1X phosphate buffer solution (PBS) at two minutes per wash. Following the 
third wash, the 1XPBS was aspirated off and the glass cover slip was suctioned to the 
bottom of the 60 mm culture dish so that the cover slip did not move around in the 
culture dish during the experiment. To achieve this, a 200 µL pipette tip was placed over 
the glass Pasteur pipet that was inserted into the tubing of the aspirator. The tip of the 
pipette tip was cut to increase the flow rate and then all remaining 1X PBS solution was 
removed, including the 1X PBS between the glass cover slip and the culture dish, 
effectively ‘adhering’ the glass cover slip to the 60 mm culture dish. 
 The next step was to prepare 625,000 B-cells in 125 uL of RPMI media to be 
adhered to the cover slips. Thus, 1 FACS tube per sample was loaded with 1 mL of 
isolated B-cells that were previously suspended at 1 million per mL after being isolated 
from the spleen. Then each sample was spun in a centrifuge at 230C for 5 minutes at 
300 G. Following centrifugation, the RPMI media was fully decanted onto a paper towel. 
Then 200 µL of 370C RPMI media was added to each FACS tube containing the 1 
million pelleted B-cells. Using a pipette set to 125 µL, the pelleted B-cells were gently 
resuspended into the 200 µL of RPMI media. Then 125 µL of resuspended B-cells were 
carefully added to the center of the corresponding cover slip within each culture dish for 
each sample. Then the samples were delicately placed in the incubator at 370C for 30 
minutes to allow the B-cells to adhere. 
 After adhering the cells, the samples were removed from the incubator and 
washed once for no more than 30 seconds with 1X PBS. Following the quick wash, 2 
mL’s of 4% PFA fixative was added to each sample and they were placed in the dark. 
The cells were then fixed for 30 minutes. During this incubation a small section of a lab 
	   17	  
bench was cleaned with 70% ethanol and then water drops were added to the cleaned 
area and a 5 inch by 5 inch piece of parafilm was placed on top. All air bubbles were 
smoothed out and this effectively ‘adhered’ the parafilm to the benchtop. This was used 
to place the MHC II antibody working solution for the adhered/fixed cells to be stained. 
 After the samples had been fixed, they were washed three times with 1X PBS 
containing 2% bovine serum albumin (BSA). The 2% BSA allows for blocking to 
decrease non-specific binding of the antibody. Each wash with the 1X PBS solution 
containing 2% BSA lasted for five minutes. During the last wash, 100 µL of the MHC II 
staining solution (3 ng/µL) was added for each sample onto the parafilm. (i.e. if there are 
five samples add five 100 µL droplets onto the parafilm.) After setting up the staining 
solutions and conducting the final wash out of the fixative, each sample was added to its 
respective 100 µL drop of staining solution. This was accomplished by taking the 60 mm 
culture dish, pinching the sides to create a gap between the cover slip and the culture 
dish large enough for a pair of tweezers to pick up the sample. Then, being sure not to 
scrap off the adhered cells with the tweezers, the sample was taken out of the culture 
dish and placed onto the 100 µL of staining solution for that sample. This was done for 
each sample and then the samples were covered, in order to prevent photobleaching 
the fluorophore.  Samples were stained for MHC II at 230C (room temperature) for one 
hour. 
 After the samples were stained, the tweezers are again used to pick the glass 
cover slip off the staining solution and then placed back into a 60 mm culture dish. The 
cover slip was placed into the culture dish so that the side of the cover slip that the cells 
are adhered to was facing up away from the bottom of the dish to prevent the B-cells 
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from being scrapped off by the rubbing against the bottom. After placing the samples 
back into their respective culture dishes, each was washed three times with ice cold 1X 
PBS for four minutes per wash. Following the last wash, each sample was mounted 
onto a microscope slide (Fischer Scientific) with 100 µL of 1X PBS in-between the glass 
cover slip with the cells adhered and the microscope slide. The edges of the glass cover 
slip were painted over with finger nail polish so to seal the adhered cells between the 
glass cover slip and microscope slide. The 100 µL of 1X PBS prevents the cells from 
drying out and keeps the samples viable for longer. The samples can then be imaged or 
stored at 40C. 
2.3 Pharmaceutical treatment protocol 
 For experiments using MβCD and cytochalasin D, treatment was conducted after 
adhering the splenic B-cells to the glass coverslip. Briefly, parafilm was added to a 
separate 60 mm culture dish where sterile water was placed between the parafilm and 
dish to ‘adhere’ the parafilm to the bottom of the dish. Then, 500 µL of MβCD or 
cytochalasin D was added on top of the parafilm and the sample was placed on top of 
the solution for treatment. Both treatments were conducted at 370C for 15 minutes. The 
remainder of the protocol followed the same steps as outlined in the previous section. 
2.4 Total internal reflection fluorescence (TIRF) microscopy instrument and analysis  
 TIRF instrumentation relied on an Olympus IX-71 microscope and motorized 
cellTIRF illuminator [11]. TIRF images were acquired over a range of penetration depths 
from 100-150 nanometers to demonstrate total internal reflection and to determine what 
penetration depth had the best resolution and lowest background. All images in this 
study are at a penetration depth of 100 nanometers with manual adjustments to the 
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angle offset to reduce the background fluorescence. TIRF images were compared to 
images acquired in the wide-field setting to ensure total internal reflection was reached. 
Images from B-cells stained for MHC II were analyzed using NIH ImageJ 
(http://rsbweb.nih.gov/ij/). The average cluster number, intensity, and relative size was 
determined by creating a region of interest for each cell, as confirmed by DIC, and 
subtracting out the background fluorescence. Then a threshold was set to analyze 
cluster parameters. Figure A below represents an example of the image analysis by 
demonstrating how a threshold is set. 
 For LPS studies comparing non-treated control cells to LPS treated cells, cells 
were normalized by determining the average Feret’s diameter of all cells analyzed for 
each particular treatment (i.e. control or LPS treated). Then all three cluster parameters 














Figure A: Representative images from Image J analysis. The B-cell was magnified considerably and 
the background was subtracted. Then a region of interest was drawn around a cell and the threshold was 
set. 
 Chapter 3: Results 
3.1 Pharmacological agents MβCD and Cytochalasin D disrupt B-cell MHC II lateral 
organization.  
 We first tested if it was possible to measure changes in MHC II lateral 
organization using TIRF microscopy by treating splenic B-cells with pharmacological 
agents capable of disrupting protein organization. Figure 1A shows representative 
images of B-cell MHC II clustering from control cells and those treated with MβCD and 
cytochalasin D. MβCD treatment resulted in a 42% decrease in number of MHC II 
clusters compared to the control (Figure 1B). In contrast, cytochalasin D treatment had 
no effect on the average number of clusters (Figure 1C).  The average intensity per cell 
was not affected by either pharmacological treatment compared to control cells (Figure 
1D & 1E). Moreover, treatment of B cells with MβCD or cytochalasin D was not 
associated with any change in the surface expression of MHC class II molecules as 
measured by flow cytometry correlating with the intensity data analysis from the TIRF 
images  (data not shown). Finally, the average cluster size as, as measured with Image 
J using a defined threshold, was not affected by MβCD or cytochalasin D (Figure 1F 
and 1G). Taken together, the micron scale images acquired using TIRF microscopy 
allowed for changes to be detected in B-cell plasma membrane MHC II lateral 
organization. 
 















































































































Figure 1: Cholesterol depletion and actin disruption have differential effects on MHC II 
clustering. (A) Representative TIRF images of MHC II staining from control, MβCD, and 
cytochalasin D treated B-cells. (B) Quantification of the average number of MHC II clusters 
expressed B-cells treated with MβCD. (C) Quantification of the average number of MHC II clusters 
expressed in the region of interest adhered for B-cells treated with cytochalasing D. (D) Average 
intensity of MHC II clusters of B-cells treated with MβCD. (E) Average intensity of MHC II clusters of 
B-cells treated with cytochalasin D. (F and D) Average cluster size of MHC II clusters on the micron 
scale for MβCD and cytochalasin D treatment respectively. Scale bar represents 5 microns. 
Asterisks represent different from control ***P < 0.001. 	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3.2 Lipopolysaccharide stimulation effects MHC II plasma membrane clustering.  
 Lipopolysaccharide (LPS) binds a complex containing Toll Like Receptor-4 
subsequently initiating a signaling cascade that leads to downstream activation (53). One 
consequence of LPS stimulation in immune cells expressing MHC II is substantially 
increased expression of MHC II protein on the plasma membrane (54). Typically, 
measuring this increase in protein expression is done using flow cytometry and indeed 
we verified that ex vivo LPS stimulation of splenic B-cells caused a stark increase in 
total surface levels of MHC II compared to unstimulated controls (data not shown). 
Therefore, we next determined how LPS stimulation affected MHC II membrane lateral 
organization using TIRF microscopy. 
 Figure 2A are representative images of B-cells with no LPS stimulation and 
twenty-four hour ex vivo LPS stimulation (1µg/ml). Due to the dramatic increase in cell 
size, the data were normalized to the amount of the surface area of the B-cell adhered. 
Correlating with the flow cytometry data, TIRF microscopy demonstrated a dramatic 
increase in MHC cluster number (Figure 2B). Interestingly, both cluster size and 
intensity were significantly decreased (Figure 2C & 2D) compared to control cells. 
Taken together, the results demonstrate that LPS not only increases MHC expression 
but that LPS activation affects MHC II clustering. 
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DIC	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Figure 2: TIRF is able to detect changes in B-cell MHC II expression with LPS stimulation. (A) 
Representative differential interference contrast (DIC) and TIRF images of MHC II staining on B-cells stimulated 
with LPS for 24 hours. (B) Quantification of the average number of MHC II clusters expressed in the region of 
interest adhered. (C) Average MHC II cluster size on the micron scale. (D) Average cluster intensity of MHC II 
clusters. Asterisks represent different from control ***P < 0.001. 	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3.3 Fish oil does not affect MHC II lateral organization.  
 MHC II molecules partially cluster on the plasma membrane within lipid rafts prior 
to any stimulus such as LPS or formation of the immunological synapse (55). We 
previously demonstrated that dietary fish oil is capable of disrupting lipid raft clustering 
upon stimulation (i.e. crosslinking GM1 molecules modeling a ligand) without 
determining how that affected raft resident protein clustering (37). Thus, we determined if 
mice fed a fish oil diet for three weeks could disrupt basal state MHC II clustering 
compared to mice fed a control diet. Figure 3A shows representative TIRF images of 
MHC II clustering on the plasma membrane of B-cells from mice fed the control and fish 
oil diets. We measured the average B-cell cluster quantity (Figure 3B) and size (Figure 
3C) and observed no differences between the diets on the micron scale. Similarly, fish 
oil had no effect on MHC II cluster intensity (Figure 3D) on a micron scale.  
 We then determined if splenic B-cells from fish oil fed mice differed from mice fed 
the control diet in MHC II lateral organization after LPS stimulation for 24 hours. Figure 
3E are representative images of B-cells from each diet stimulated with LPS. Cluster 
quantity was elevated compared to non-stimulated cells, which corresponds with 
increased surface intensity as measured with flow cytometry (data not shown). This 
agrees with other studies that have indicated increased MHC II expression and 
increased cell size with LPS stimulation (54). 
























































Figure 3: Fish oil has no effect on B-cell MHC II lateral organization.  
(A) Representative differential interference contrast (DIC) and TIRF images of MHC II staining on B-cells 
isolated from mice fed either the control or fish oil diet. (B) Quantification of the average number of MHC II 
clusters expressed in the region of interest adhered. (C) Average MHC II cluster size on the micron scale. (D) 
Average cluster intensity of MHC II clusters. Scale bar represents 5 microns. 	  

































































Figure 3: Fish oil effects B-cell MHC II lateral organization upon LPS stimulation.  
(E) Representative differential interference contrast (DIC) and TIRF images of MHC II staining on B-cells 
isolated from mice fed either the control or fish oil diet and stimulated with LPS for 24 hours. (F) Quantification 
of the average number of MHC II clusters expressed in the region of interest adhered. (G) Average MHC II 
cluster size on the micron scale. (H) Average cluster intensity of MHC II clusters. Asterisks represent different 
from control ***P < 0.001. 	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While slightly elevated in fish oil fed mice, cluster quantity showed no statistical 
difference between the two diets when stimulated with LPS (figure 3F). However, both 
cluster size and intensity was significantly increased in aged mice fed fish oil in 
comparison to mice fed the CD (figure 3G and 3H). To ensure these differences were 
not due to changes in the surface area adhered we quantified the area adhered as done 
in the non-diet stimulated cells as no differences were discovered (data not shown). 
3.4 B-cells from aged mice  
 Finally, we addressed how MHC II clustering is affected in an aged phenotype. 
Aging has been demonstrated to decrease B-cell numbers, physiological function, as 
well as diminish the amount of omega-3 fatty acids that are present in the plasma 
membrane (41, 42). Therefore, we analyzed clustering quantity, intensity, and number 
using TIRF as done in each of the previous experiments. Figure 4A are representative 
images of B-cells from young and aged mice stained for MHC II. Cluster quantity 
showed no difference between B-cells from young mice and B-cells from aged mice 
(Figure 4B). Similarly, cluster size and intensity did not differ between either phenotype 
(Figure 4C & D). 
 Then, as was done in the fish oil experiments, the aged splenic B-cells were 
isolated and stimulated with LPS for 24 hours. Figure 4E are representative images of 
between young and aged B-cells stimulated with LPS. When examining cluster 
parameters cluster quantity and size were significant (Figure 4F and 4G). However, 
cluster intensity did not change (Figure 4H). 
  






















































Figure 4: Aging has no effect on B-cell MHC II lateral organization.  
(A) Representative differential interference contrast (DIC) and TIRF images of MHC II staining on B-cells 
isolated from mice young and aged mice. (B) Quantification of the average number of MHC II clusters 
expressed in the region of interest adhered. (C) Average MHC II cluster size on the micron scale. (D) 
Average cluster intensity of MHC II clusters. 	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Figure 4: Aging effects B-cell MHC II lateral organization upon LPS stimulation.  
(E) Representative differential interference contrast (DIC) and TIRF images of MHC II staining on B-cells 
isolated from mice that were either young or aged and stimulated LPS for 24 hours. (F) Quantification of the 
average number of MHC II clusters expressed in the region of interest adhered. (G) Average MHC II cluster size 
on the micron scale. (H) Average cluster intensity of MHC II clusters. Asterisks represent different from control 
**P < 0.005. 	  
Chapter 4: Discussion 
 This research focused on developing an efficient TIRF approach to evaluate 
membrane protein organization. More specifically, these data demonstrate that TIRF 
microscopy can detect changes in ex vivo B-cell MHC II lateral organization using a 
monoclonal antibody under differing conditions. First, it was demonstrated that the TIRF 
protocol is viable and capable of detecting changes in MHC II membrane organization 
using pharmacological agents capable of disrupting protein clustering. Next, the data 
showed that neither a relevant dose of fish oil, nor aging the mice approximately nine 
months, had an affect on MHC II clustering in the absence of LPS stimulation. Taken 
together, the data establish the TIRF protocol as a relevant alternative to more costly 
and time consuming approaches to address membrane protein clustering. 
4.1 MβCD disrupts ex vivo B-cell MHC II clustering 
 The rationale for studying ex vivo B-cell MHC II organization was based on past 
studies conducted in our laboratory evaluating lipid raft size using differing forms of 
microscopy (56). Multiple studies have shown that MHC II localizes within lipid rafts in 
both the absence and presence of a stimulus (55). Some have even proposed that newly 
synthesized MHC class II molecules are trafficked directly to lipid raft domains (57). Thus, 
it was a logical protein candidate to evaluate if the TIRF protocol was efficacious.  
 MHC II clustering is dependent on the underlying lipid environment and the 
protein resides in lipid raft-like domains to enhance antigen presentation to T-cells (58). 
We first used pharmacological agents capable of disrupting either the lipid environment 
(MβCD) or the underlying cytoskeleton that influences protein organization in the 
plasma membrane (cytochalasin D). Previously, Vrljic 
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cholesterol with MβCD decreased MHC class II diffusion (59). The TIRF data appear to 
be in agreement with this study as MHC II cluster quantity was diminished. Removing 
cholesterol from the plasma membrane also generates solid-like domains (60), i.e. 
containing lipids with a high melting temperature. This process slows protein diffusion 
and limits the number of protein clusters dispersed around plasma membrane as can be 
seen in Figure 1A. 
 The actin cytoskeleton also serves a role in clustering membrane proteins on the 
plasma membrane surface (61). It was previously demonstrated that B cells treated with 
cytochalasin D did not change the diffusion or clustering of membrane bound MHC II 
proteins (55, 62). The data presented here correlate with this finding, as TIRF images 
revealed no difference in any of the MHC II clustering parameters upon quantification. 
While other studies have demonstrated that cytochalasin D does affect MHC II protein 
clustering this may be a result of scale.  Meaning, the cytoskeleton may impact 
nanoscale spatial distribution of MHC class II molecules but may not remodel the 
surface organization to the extent that it can be observed at the micron scale. Taken 
together, the data show that the approach used to evaluate MHC II on the micron scale 
with TIRF is capable of detecting differences in MHC II clustering as removing 
cholesterol from the membrane with MBCD caused a substantial decrease in MHC II 
cluster number compared to the control. 
4.2 No changes in MHC II lateral organization in the basal state 
 Studies with immortal B-cells suggest that MHC II proteins are partially clustered 
in the basal state (i.e. in the absence of a stimulus) (12, 55). However, what role these 
clusters play in cellular function is unclear. Using the experimental conditions of dietary 
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fish oil and aging we investigated the same cluster parameters as with the 
pharmacological treatment using our TIRF protocol. The merits of choosing dietary fish 
oil have already been discussed however the rationale for studying MHC II clustering in 
the context of aging is multifaceted. Aging in humans and animal models results in the 
inability to make an optimal immune response to vaccines and infectious agents (41, 42). 
A potential contributing factor to the age-adapted immune response is the affect aging 
has on B-cell subsets and function (41, 42). One hallmark or aging is a decreased humoral 
response and molecular immunological mechanisms in B-cells (41, 42). Thus B-cell MHC 
II was again a logical choice to study since it is a vital protein in propagating the 
humoral immune response.  
 Thus, we determined the cluster quantity, size, and intensity in the context of 
dietary fish oil and aging. In all three categories the data remained unchanged in either 
experimental condition. Its important to note that while on the micron scale there is no 
change in MHC II lateral organization it does not mean any change is not present or 
possible. Clustering in the absence of stimulus is extremely dynamic and on a much 
smaller scale than when protein is engaged with a ligand or, as with MHC II, the 
immunological synapse (12, 55, 63). Thus, one explanation for our TIRF protocol not being 
able to detect changes is due to the nanoscale heterogeneity displayed by membrane 
microdomains containing MHC II (5). These proteins have an intrinsic ability to cluster 
however the clustering becomes more efficient upon the loading of derived antigenic 
peptide (23, 25). Therefore, moving forward it would be of interest determine if our TIRF 
approach could detect changes in MHC II clustering at the B-T cell immunological 
synapse ex vivo in the context of aging and dietary fish oil. 
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4.3 TIRF microscopy revealed changes in MHC II clustering upon ex vivo LPS 
stimulation. 
 LPS is a component of the cell wall of gram-negative bacteria capable of 
activating B-cells and leads to the production and secretion of small proteins that can 
induce inflammation known as proinflammatory cytokines (64). The other, more relevant, 
aspect to LPS stimulation is it dramatically increases the expression of MHC II and cell 
size (54, 65). LPS is also known as a PAMP (pathogen associated molecular patterns) 
because of its repetitive epitope that stimulates TLR4 (66). Recognition of LPS by TLR4 
involves four proteins: the LPS binding protein, CD14, lymphocyte antigen 96 
(commonly referred to as MD-2), and TLR4. CD14/MD-2/TLR4 must cluster together 
and form a trimolecular complex in order to activate the cell (66). Recent data published 
in Nature Immunology demonstrates that, outside of its classical function in antigen 
presentation, MHC II can act as a signal transducer to promote TLR4 signaling (67). 
Moreover, in the context of increased MHC II expression in response to LPS, to our 
knowledge no other study address how the ex vivo B-cell MHC II clustering changes 
using TIRF upon LPS stimulation. 
 Previous data from our laboratory show that mice fed the fish oil diet have an 
enhancement of B-cell activation in the presence of LPS (37). We previously 
hypothesized that one possible explanation for this data is the fish oil increased lipid 
rafts size and therefore could affect proteins involved in B-cell activation. While a 
correlation between lipid raft size and enhanced cellular function is hypothetical, other 
studies suggest this conclusion as well (68, 69). Meaning, the “larger” the size of the lipid 
raft the stronger the signaling response. However, understanding what “increased lipid 
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raft size” means for proteins that localize within rafts is unclear. Since MHC II localize in 
rafts it is an ideal target of study. 
 We first wanted to determine how B-cell MHC II clustering was affected by a 24 
hour ex vivo LPS stimulation in the absence of any other condition such as fish oil or 
age. As expected, the surface adhered increased when compared to unstimulated cells 
because the cell size was increased due to LPS stimulation as reported by multiple 
studies and our own flow cytometry data (data not shown). However, our data reveal 
that upon normalizing the clustering parameters for area of the surface of the cell that 
adhered to the glass slides, MHC II cluster quantity was increased while cluster size 
and intensity was decreased. Increased cluster number can be rationalized with 
increased expression of MHC II. However, when coupled with the cluster size and 
intensity data it becomes more significant. The data suggest that upon LPS stimulation, 
not only does MHC II increase in content, the way in which MHC II proteins cluster is 
changed. The clusters are smaller and less intense, which would not be revealed in 
studies that use excessive staining or over expression of MHC II proteins tagged with a 
fluorophore. In those instances, fluorophore saturation and background fluorescence 
become issues in resolving those particular cluster parameters. Meaning, as more MHC 
II proteins are expressed on the plasma membrane they cluster in smaller quantities, 
which individually take up less fluorophore than larger clusters would. Of course, this is 
assuming that the amount of fluorescently labeled antibody is kept at a relatively low 
concentration (i.e. not saturating) which is one aspect utilized in our protocol. Thus, the 
data reveal, for the first time, that ex vivo B-cell MHC II lateral organization changing up 
LPS stimulation. 
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4.4 Fish oil effects ex vivo B-cell MHC II clustering when stimulated LPS 
 After discovering LPS changes in MHC II clustering could be distinguished using 
our TIRF protocol we addressed how animals fed the control diet and fish oil diet for 
three weeks affected MHC II clustering after LPS stimulation for 24 hours. While there 
was no change between the diets in regards to cluster quantity the data revealed that 
dietary fish oil increased cluster quantity and size. This data is intriguing as it has been 
hypothesized by many that fish oil makes the membrane more fluid allowing for easier 
association between membrane receptors (70, 71). Indeed, our own data regarding 
increased lipid raft size upon fish oil treatment would seem to correlate well with larger 
LPS stimulated MHC II clusters that are more intense. However, more data must be 
collected before attempting to correlate lipid rafts and MHC II clustering. Future dual 
labeling studies involving lipid raft staining with MHC II staining would shed more light 
on this potential correlation. One would expect if MHC II expression was substantially 
increased to the point of having physiological relevance our data would show a dramatic 
increase in all three clustering parameters. 
4.5 Aged splenic B-cells display different MHC II clustering with LPS stimulation 
 Stimulating splenic B-cells from aged mice resulted in an increase in cluster 
quantity and size without a corresponding increase in intensity. Moreover, the standard 
intensity units of measure were significantly lower with aged B-cells compared to 
untreated and fish oil treated B-cells. However, the intensity was elevated compared to 
B-cells young animals but again not significant. These data are difficult to interpret as 
there is very little literature on expression in splenic B-cells from aged animals. It has 
been shown that omega-3 polyunsaturated fatty acids are decreased in the plasma 
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membrane with aging so perhaps the fluidity of the membrane is limited causing the 
size of the clusters to increase. However, this is speculative as a corresponding 
increase in cluster intensity and decrease in cluster quantity would be expected. Much 
more investigation is needed to truly determine the significance of these data. It would 
be of interest to determine how aging (41, 42) affects lipid raft clustering as we have done 
in our previous publications to provide more insight into the capability of the aged 
plasma membrane to organize in response to a stimulus. Moreover, determining how 
signaling is affected in response to LPS stimulation and the formation of the 
immunological synapse using splenic B-cells from aged mice would help address the 
underlying gaps of knowledge.  
4.6 Conclusion 
 Collectively these data demonstrate the validity of our TIRF protocol. It appears 
the major differences regarding MHC II lateral organization are not in the basal state but 
upon activation as our most recent publication demonstrates (63). This correlates with 
our data that demonstrate lipid raft clustering is diminished up dietary fish oil 
intervention where we cross-linked GM1 molecules using cholera toxin B to mimic a 
protein binding its ligand. More data is needed to determine what the physiological 
relevance of LPS stimulated MHC II clustering is and if there is any interaction between 
MHC II and TLR-4. Moreover, it should be noted that the cluster parameters here are in 
the context of the TIRF protocol and ImageJ analysis. For example, the cluster size 
parameter should not be taken as the actual size of an MHC cluster in vivo but rather an 
approximation to detect differences in treatment. Moreover, the size measurement can 
be easily influenced by clusters that are in close proximity to one another with the region 
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of interest. The closer the proximity of the clusters the higher the likely hood the 
threshold will recognize only one large cluster as opposed to multiple smaller clusters. 
Thus, there are much more eloquent systems such as Dr. Pierces research in which 
planar lipid bilayers were attached to glass cover slips to study “live” B-cell receptor 
clustering (21). By no means is this a comparison to such innovative and complex 
systems. Each TIRF protocol and approach have their benefits and drawbacks. Our 
approach does not allow for the benefits of live cell imaging however it is extremely 
difficult to transfect primary cell lines for live cell imaging. Even upon transfection the 
physiological relevance of such systems is questionable. The approach taken with our 
protocol attempts to bridge the gap by studying ex vivo protein clustering with a 
monoclonal antibody at a low concentration. This approach to TIRF is to be coupled 
with other forms of microscopy, as well as other experimental approaches, to address 
membrane organization and protein clustering.
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